Nantahala Capital Management, LLC - 16 Feb 2025 SCHEDULE 13G/A Report for Eagle Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (EGRX)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
Eagle Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
EGRX
Shares outstanding
13M shares
Disclosed Ownership
4.95M shares
Ownership
38.1%
Form type
SCHEDULE 13G/A
Filing time
19 Feb 2025, 16:32:10 UTC
Date of event
16 Feb 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 38.08% 4.95M 0 4.95M /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer
Wilmot B. Harkey 38.08% 4.95M 0 4.95M /s/ Wilmot B. Harkey Wilmot B. Harkey / Manager
Daniel Mack 38.08% 4.95M 0 4.95M /s/ Daniel Mack Daniel Mack / Manager